Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme.
about
Prostate cancer nomograms: a review of their use in cancer detection and treatment.Prostate cancer in Asian men.Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis.Androgen receptor coactivator p120 subtype β is highly expressed in prostate cancer.Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range.The roles of prostate-specific antigen (PSA) density, prostate volume, and their zone-adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0 ng/mL.
P2860
Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Development and external valid ...... volume-adjusted biopsy scheme.
@en
type
label
Development and external valid ...... volume-adjusted biopsy scheme.
@en
prefLabel
Development and external valid ...... volume-adjusted biopsy scheme.
@en
P2093
P2860
P356
P1476
Development and external valid ...... volume-adjusted biopsy scheme.
@en
P2093
M Miyakubo
P2860
P2888
P304
P356
10.1038/PCAN.2011.62
P577
2011-12-06T00:00:00Z
P6179
1044755265